News

The PSNC's talks with the government will focus on a long-term deal, FMD and prescription payments.

The English Pharmacy Board member calls for an independent review of money paid to GPhC council members.

The remote supervision petition is edging closer to forcing a government response.

Over 40 bodies have set out a national strategy to improve the detection and treatment of cardio disease. 

Brian Collett brings you the latest clinical news.

A one-week study found pharmacies recorded 221,091 interactions with people about their blood pressure.

The MHRA recalls three batches of irbesartan amid an investigation into possible NDEA contamination.

As the reforms to general practice start, the next year is critical for community pharmacy, says Simon Dukes.

Uncertainty persists around the number of medicine packs in the supply chain that have FMD safety features.

Liz Fidler wants to increase technicians network as APTUK undergoes “critical time in its sustainability.”

The PSNC chief says it has prevented over £330 million in concessionary losses for contractors.

GP consultations for flu-like illnesses went up slightly over a seven-day period.

The UK will drop out of FMD in the event of a no-deal Brexit, warns the ABPI.

GPhC chief Duncan Rudkin promised the regulator will “take a pragmatic and proportionate approach” to FMD.

NHS stop smoking services in England helped more than 50,000 give up the habit.

The British Medical Association criticises a new law giving pharmacists special dispensing powers.

PSNC chief Simon Dukes said pharmacy negotiations with the government have been delayed because of Brexit.

Boots creates new role allowing pharmacists to use their clinical knowledge to design services.

The NPA urges the government to give community pharmacy a multi-year funding deal.

The DHSC announced its final list of drug price concessions for January on the last day of the month.